Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PBMC for Endometrial Cell Populations in Infertility
NCT05421364Recruiting
- Sponsor
- Nadezhda Women's Health Hospital
- Start
- Dec 2023
- Primary completion
- Jan 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous G-CSF mobilized peripheral blood mononuclear cells in female infertility, sponsored by Nadezhda Women's Health Hospital. Primary endpoints: Change in the numbers of certain endometrial cell populations, Change in the percentages of the immune cells in the endometrial stroma and 1 more. Started Dec 2023; status: recruiting.
02
Drugs
autologous G-CSF mobilized peripheral blood mononuclear cells
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT05421364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05421364.